|
Age at insulin initiation, years [N = 511]
|
62.2 ± 10.0
|
|
Gender [N = 511]
| |
|
Male
|
326 (63.8%)
|
|
Female
|
185 (36.2%)
|
|
Duration of diabetes, years [N = 504]
|
11.8 ± 8.8
|
|
Duration of diabetes category [N = 504]
| |
|
<5 years
|
99 (19.6%)
|
|
≥5, <10 years
|
125 (24.8%)
|
|
≥10, <15 years
|
134 (26.6%)
|
|
≥15 years
|
146 (29.0%)
|
|
HbA1c (%) [N = 506]
|
10.3 ± 2.0
|
|
HbA1c category [N = 506]
| |
|
≤8.0%
|
57 (11.3%)
|
|
>8.0%, ≤10.0%
|
197 (38.9%)
|
|
>10.0%, ≤12.0%
|
169 (33.4%)
|
|
>12.0%
|
83 (16.4%)
|
|
FPG (mg/dL) [N = 254]
|
217.3 ± 80.8
|
|
PPG (mg/dL) [N = 329]
|
296.1 ± 96.0
|
|
BMI (kg/m2) [N = 490]
|
23.9 ± 4.0
|
|
Insulin regimen
| |
|
Basal
|
32 (6.3%)
|
|
Basal + short-acting
|
134 (26.2%)
|
|
Short-acting
|
130 (25.4%)
|
|
Premix
|
188 (36.8%)
|
|
Other
|
27 (5.3%)
|
|
Microvascular diabetic complication [N = 505]
|
421 (83.4%)
|
|
Nephropathy [N = 500]
|
304 (60.8%)
|
|
Microalbuminuria [N = 498]
|
178 (35.7%)
|
|
Macroalbuminuria [N = 505]
|
185 (36.6%)
|
|
Renal failure [N = 509]
|
78 (15.3%)
|
|
Retinopathy [N = 508]
|
209 (41.1%)
|
|
Peripheral neuropathy [N = 509]
|
265 (52.1%)
|
|
Foot ulcer [N = 510]
|
7 (1.4%)
|
|
Macrovascular disease [N = 510]
|
128 (25.1%)
|
